Loading data
DSGNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 59.13 m USD | 44.35 m USD | 57.06 m USD | 48.61 m USD | 24.78 m USD |
| Operating profit | -79.47 m USD | -62.38 m USD | -78.19 m USD | -67.59 m USD | -35.83 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -69.79 m USD | -49.59 m USD | -66.86 m USD | -63.31 m USD | -35.53 m USD |
| Basic earnings per share | -1.22 USD/share | -0.88 USD/share | -1.19 USD/share | -1.14 USD/share | -0.77 USD/share |
| Diluted earnings per share | -1.22 USD/share | -0.88 USD/share | -1.19 USD/share | -1.14 USD/share | -0.77 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.